Currently funded projects

The Kids' Cancer Project has committed over $75 million to research projects across Australia.
Categories
  • Various cancer types

Reboot-Kids

Recipient: Dr Jennifer Cohen and Professor Claire Wakefield Institute: Sydney Children’s Hospital, Kids Cancer Centre Funding: $249,972 July 2019 to June 2023
Categories
  • Various cancer types
  • Translate

Pre-clinical anti CD-47 therapy

Recipient: Dr Raelene Endersby and Professor Nick Gottardo Institute: Telethon Kids Institute Funding: $98,716 July 2021 to June 2022
Categories
  • DIPG

Targeting Polo-like kinase 1 as a novel therapeutic opportunity for diffuse intrinsic pontine glioma

Recipient: Associate Professor David Ziegler Institute: Sydney Children's Hospital TKCP funding: $278,282 July 2019 to June 2022 PdCCRS* funding: $278,282 Total funding: $556,563
Categories
  • Various cancer types

The NORTH Trial

Recipient: Dr Paul Wood Institute: ANZCHOG Funding: $61,420 July 2018 to June 2024
Categories
  • Neuroblastoma

"Cage fighting" with neuroblastoma

Recipient: Dr Andrew Care Institute: Macquarie University The Kids’ Cancer Project funding: $63,926 May 2020 to April 2023 PdCCRS* funding: $127,854 Total funding: $191,780
Categories
  • Sarcoma

Intraoperative immunotherapy to prevent relapse in soft tissue sarcoma

Recipient: Dr W Joost Lesterhuis Institute: Telethon Kids Institute TKCP funding: $197,525 April 2020 to March 2022 PdCCRS* funding: $395,050 Total funding: $197,525
Categories
  • Medulloblastoma
  • Translate

Using smarter new drugs to reduce long term debilitating side effects for aggressive childhood brain

Recipient: Professor Nick Gottardo and Dr Raelene Endersby  Institute: Telethon Kids Institute Funding: $246,713 July 2020 to June 2021
Categories
  • Various cancer types

International clinical trials support

Recipient: ANZCHOG Institution: Monash University TKCP Funding: $600,000 January 2024 to December 2026 Previous Funding: $1,075,000 July 2015 to December 2024
Categories
  • Various cancer types

Personalised Medicine: Zero Childhood Cancer

Recipient: Professor Michelle Haber Institute: Children’s Cancer Institute Funding: $1,902,550 July 2014 to September 2021
Categories
  • Medulloblastoma

Exploiting CDK4/6 inhibition to treat medulloblastoma

Recipient: Professor Brandon Wainwright Institute: University of Queensland TKCP funding: $196,207 July 2019 to June 2022 PdCCRS* funding: $392,413 Total funding: $588,620
Categories
  • Leukaemia

Targeting the NAD pathway as a new therapeutic strategy for high-risk leukaemia in children

Recipient: Dr Michelle Henderson Institute: University of NSW TKCP funding: $138,179 July 2019 to June 2022 PdCCRS* funding: $453,279 Total funding: $591,458
Categories
  • Leukaemia

IntReALL-HR

Recipient: Associate Professor Tamas Revesz Institute: Women's and Children's Hospital, Adelaide Funding: $416,422 July 2018 to June 2022
Categories
  • Various cancer types

Understanding the genetic basis of chemotherapy-induced cardiomyopathy

Recipient: Dr Rachel Conyers Institute: The Murdoch Children’s Research Institute Funding: $583,072 July 2018 to December 2023
Categories
  • Various cancer types

New state-wide Children’s and Adolescent/Young Adult Cancer Clinical Trials Unit

Recipient: Associate Professor John Heath Institute: Royal Hobart Hospital Funding: $308,517 July 2017 to December 2022
Categories
  • Leukaemia

Pre-clinical development of novel immune therapy for paediatric cancers

Recipient: Dr Alla Dolnikov Institute: Sydney Children's Hospital, Randwick Funding: $480,000 July 2016 to December 2022
Categories
  • Leukaemia

Investigating drug resistance and genetic changes in Ph-like ALL in adolescents

Recipient: Dr Susan Heatley Institute: South Australian Health & Medical Research Institute Funding: $398,146 July 2016 to June 2022
Categories
  • DIPG

Epigenetic targeted therapy in DIPG

Recipient: Associate Professor David Ziegler Institute: Children’s Cancer Institute Funding: $251,428 July 2019 to May 2022
Categories
  • Various cancer types

Impact of treatment on late effects and survivorship on childhood cancer survivors

Recipient: Professor Natasha Nassar Institute: University of Sydney Funding: $39,578 July 2019 to December 2021
Categories
  • Various cancer types

Developing treatments for vincristine-induced neuropathy

Recipient: Associate Professor Irina Vetter Institute: The University of Queensland Funding: $255,978 July 2019 to August 2021
Categories
  • Testicular

Development of a non-invasive diagnostic and prognostic assay for adolescent testicular cancer

Recipient: Dr Cassy Spiller Institute: The University of Queensland Funding: $50,000 July 2019 to December 2021
Categories
  • Neuroblastoma

MicroRNA drugs for the treatment of neuroblastoma

Recipient: Associate Professor Alexander Swarbrick Institute: Garvan Institute of Medical Research Funding: $308,270 July 2018 to September 2021
Categories
  • Various cancer types

3D printers and mini-brains

Recipient: Associate Professor Geraldine O’Neill Institute: The Children’s Hospital at Westmead Funding: $119,821 July 2019 to June 2020
Categories
  • Leukaemia

Overcoming therapeutic resistance in high risk ALL using novel BH3 mimetic

Recipient: Dr Diane Hanna Institute: The Walter and Eliza Hall Institute Funding: $100,000 July 2019 to September 2020
Categories
  • Medulloblastoma
  • Translate

Using targeted chemotherapies to reduce intensity of radiotherapy in medulloblastoma

Recipient: Dr Nick Gottardo Institute: Telethon Kids Institute Funding: $256,342 July 2018 to June 2020
Categories
  • Various cancer types

New therapies for incurable paediatric brain tumours

Recipient: Professor Brandon Wainwright Institute: The Institute for Molecular Bioscience Funding: $224,936 July 2018 to June 2020
Categories
  • Leukaemia
  • Translate

Combinational therapeutics in high-risk infant acute lymphoblastic leukaemia

Recipient: Dr Rishi Kotecha Institute: Telethon Kids Institute Funding: $445,695 July 2017 to June 2020
Categories
  • Leukaemia

Reversing glucocorticoid resistance in paediatric acute lymphoblastic leukaemia – a novel epigenetic

Recipient: Professor Richard Lock Institute: Children’s Cancer Institute Funding: $103,571 July 2017 to June 2020
Categories
  • Various cancer types

Ready, Steady, School

Recipient: Dr Joanna Fardell Institute: UNSW Australia Funding: $523,308 July 2016 to December 2020
Categories
  • Neuroblastoma

Targeting FACT to inhibit MYCN-driven transcription in neuroblastoma

Recipient: Dr Daniel Carter Institute: UNSW Australia Funding: $296,428 July 2016 to June 2020
Categories
  • Sarcoma

Exploring better and safer treatments for osteosarcoma

Recipient: Associate Professor Christine Hawkins Institute: La Trobe University Funding: $382,713 July 2016 to June 2020
Categories
  • Leukaemia

Therapeutic targeting transcriptional addiction in paediatric leukaemias

Recipient: Professor Ricky Johnstone Institute: Peter MacCallum Cancer Centre Funding: $496,282 July 2016 to June 2020
Categories
  • DIPG

Synthetic retinoid therapy for diffuse intrinsic pontine glioma

Recipient: Associate Professor David Ziegler Institute: Children’s Cancer Institute Funding: $200,000 July 2016 to December 2020
Displaying results 65 - 96 of 118
Pages